Both FDA-approved and -unapproved FMT products should play a role in preventing C. diff infections, according to Dr. Jessica Allegretti.
AI may soon be able to provide real-time feedback on quality metrics during endoscopic procedures, according to Dr. Nayantara Coelho-Prabhu.
EMVI and positive pelvic sidewall lymph nodes were associated with higher rates of tumor regrowth in patients with rectal cancer.
Gastroenterologists should pursue emergent endoscopic removal of foreign objects in those with symptoms of obstruction, says Dr. Sumeet Tewani.
A retrospective cohort study shows that GLP-1 agonists reduced the risk of cirrhosis and HCC in patients with MASLD and Type 2 diabetes.
You don’t build a network by saying no — but you have to follow through, says Dr. Maria Abreu.
Gastroenterologists should be aware of evolving guidance on bowel preparations for patients taking GLP-1 agonists, says Dr. Jennifer Weiss.
Improving your brain health starts with improving metabolic health, says Dr. Michael Hoffmann.
Upcoming AGA guidelines on moderate-to-severe ulcerative colitis help to make sense of new therapies and mechanisms while advising on treatment strategies such as combinations and de-escalation.
When physicians cannot provide the care they know patients need, our entire healthcare system suffers, explains Dr. Wendy Dean.
